Home / Press Coverage / MedCity News | How the IRA Has Created a New Environment for Biosimilars

MedCity News | How the IRA Has Created a New Environment for Biosimilars

January 5, 2024

By Maximillian Vargas and Caitlin Verrilli

As IRA provisions are activated, the law’s impact on biologics and biosimilars will become more apparent. By using both the carrot and the stick, the IRA may finally…

Recommended for you

Certara Showcases 2024 Research Wins with Over 100 Papers Published

Press Release

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

Announcement

Automated Writing Without the Compromise

Fact Sheet

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

Poster

MedCity News | How the IRA Has Created a New Environment for Biosimilars

MedCity News | How the IRA Has Created a New Environment for Biosimilars

Certara Showcases 2024 Research Wins with Over 100 Papers Published

Major Release of Certara GlobalSubmit™ Software Enhances the Regulatory Submission Process

Automated Writing Without the Compromise

Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Treatment of Patients with Severe Hypertriglyceridemi

Newsletter sign up

Quick links

Solutions

Contact